A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
City of Hope Medical Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Children's Oncology Group
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
Roswell Park Cancer Institute
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center